1. Home
  2. JMM vs IXHL Comparison

JMM vs IXHL Comparison

Compare JMM & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Multi-Market Income Fund (MA)

JMM

Nuveen Multi-Market Income Fund (MA)

N/A

Current Price

$6.10

Market Cap

58.1M

Sector

Finance

ML Signal

N/A

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$0.43

Market Cap

49.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
JMM
IXHL
Founded
1988
2001
Country
United States
Australia
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
58.1M
49.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
JMM
IXHL
Price
$6.10
$0.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
16.1K
23.8M
Earning Date
01-01-0001
11-14-2025
Dividend Yield
5.44%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$12,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.29
$0.08
52 Week High
$6.10
$2.25

Technical Indicators

Market Signals
Indicator
JMM
IXHL
Relative Strength Index (RSI) 42.49 59.02
Support Level $6.06 $0.35
Resistance Level $6.15 $0.50
Average True Range (ATR) 0.04 0.03
MACD 0.00 0.02
Stochastic Oscillator 31.93 68.63

Price Performance

Historical Comparison
JMM
IXHL

About JMM Nuveen Multi-Market Income Fund (MA)

Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

Share on Social Networks: